SynopsisGlobal Chronic Hepatitis B Drugs market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key companies engaged in the Chronic Hepatitis B Drugs industry include GSK, Bri.....
SynopsisGlobal Hepatitis B Antiviral Drugs market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key companies engaged in the Hepatitis B Antiviral Drugs industry include GSK,.....
SynopsisGlobal Hepatitis B Treatment Oral Medicine market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key manufacturers engaged in the Hepatitis B Treatment Oral Medicine i.....
SynopsisGlobal Hepatitis C Treatment Medications market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key companies engaged in the Hepatitis C Treatment Medications industry .....
SynopsisGlobal Hepatitis C Treatment Direct-Acting Antiviral (DAA) market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key manufacturers engaged in the Hepatitis C Treatment.....
SynopsisGlobal Hepatitis C Treatment Oral Medicine market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key manufacturers engaged in the Hepatitis C Treatment Oral Medicine i.....
SynopsisGlobal Cilostazol Tablets market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key manufacturers engaged in the Cilostazol Tablets industry include Otsuka Pharmaceuti.....
SynopsisGlobal Heparin Anticoagulant Drugs market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key manufacturers engaged in the Heparin Anticoagulant Drugs industry include .....
SynopsisGlobal Medical Heparin Injection market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key manufacturers engaged in the Medical Heparin Injection industry include Sano.....
SynopsisHard carbon is currently the mainstream anode material route for sodium batteries. The commonly used hard carbon precursors are mainly bio-based, such as moso bamboo, coconut shell, starch, walnut shell, etc. Global Biomass Hard Carbon Anode Precursor ma.....
